Synthesis of a Substance P Antagonist with a Somatostatin Scaffold: Factors Affecting Agonism/Antagonism at GPCRs and the Role of Pseudosymmetry
- 29 September 2000
- journal article
- letter
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 43 (21) , 3827-3831
- https://doi.org/10.1021/jm000316h
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Modulation of Receptor and Receptor Subtype Affinities Using Diastereomeric and Enantiomeric Monosaccharide Scaffolds as a Means to Structural and Biological Diversity. A New Route to Ether SynthesisJournal of Medicinal Chemistry, 1998
- Opioid Peptides: Simultaneous δ Agonism and μ Antagonism in Somatostatin AnaloguesPeptides, 1997
- De novo design and synthesis of somatostatin non-peptide peptidomimetics utilizing .beta.-D-glucose as a novel scaffoldingJournal of the American Chemical Society, 1993
- On the origins of the DNA sequence selectivity of mitomycin monoalkylation transformationsJournal of the American Chemical Society, 1992
- A super active cyclic hexapeptide analog of somatostatinLife Sciences, 1984
- A potent cyclic hexapeptide analogue of somatostatinNature, 1981
- Conformationally restricted bicyclic analogs of somatostatin.Proceedings of the National Academy of Sciences, 1978
- Variability of the duration of inhibition of growth hormone release by Nα-acylated-des-[Ala1-Gly2]-H2somatostatin analogsBiochemical and Biophysical Research Communications, 1975
- Somatostatin. Total solid phase synthesisJournal of the American Chemical Society, 1974
- Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth HormoneScience, 1973